Cloud revenue in the quarter of $12 billion—a 30% increase from last year—just missed analyst estimates of $12.2 billion.

We recently published a list of 10 Mid-Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a look ...

Barclays analyst Andrew Lazar raised the firm’s price target on BellRing Brands (BRBR) to $85 from $79 and keeps an Overweight rating on the ...

Meta shares moved higher Tuesday after setting a record close yesterday, as investors bid up the stock in the aftermath of a solid quarterly earnings report and optimism about the company's AI-related ...

Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $252.4 billion by market cap, ...

The consensus price target hints at a 25.4% upside potential for Fortune Brands Innovations (FBIN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...

BofA lowered the firm’s price target on BioNTech (BNTX) to $147 from $150 and keeps a Buy rating on the shares. On the Q4 call, the firm will ...

Shares of Chewy, Inc. (NYSE:CHWY – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-three ratings firms that are currently covering the stock, Marketbeat reports.

Innate Pharma (NASDAQ:IPHA – Get Free Report) and Agenus (NASDAQ:AGEN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based ...